Category: Other Industries
Country/Region: China State/Province: Beijing
Main Products: Zolmitriotan/Voriconazole/Voglibose/Cefozopran/Pruliflocxacin/Biapenem/, Zolmitriotan/Voriconazole/Voglibose/Cefozopran/Pruliflocxacin/Biapenem/
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2012, 2012
Legal Status: Agency
Ownership: Professional Association
Employees: 201 - 300 People
Factory Size: 3, 000-5, 000 square meters
R&D Team Size: 5 - 10 People
Certifications: BSCI
Contact Person: Xi Tina
Designation: Owner
Department: Director/CEO/General Manager
Telephone: 86-10-64945853
Main Markets: Australia (24%) South Korea (24%) Canada (21%) Germany (13%) United Kingdom (12%)
Export Focus: Australia, Canada, Germany, South Korea, United Kingdom
Contract Services: Buyer Label Offered
Annual Revenue: Approx 2 Million US Dollar
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 21% - 30%
Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Western Union (WU), Cash